These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18641842)

  • 1. [New concepts on diabetic retinopathy: neural versus vascular damage].
    Serrarbassa PD; Dias AF; Vieira MF
    Arq Bras Oftalmol; 2008; 71(3):459-63. PubMed ID: 18641842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
    Barber AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of retinal neurodegeneration as a result of diabetes mellitus].
    Lang GE
    Klin Monbl Augenheilkd; 2013 Sep; 230(9):929-31. PubMed ID: 23986191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases.
    Sundstrom JM; Hernández C; Weber SR; Zhao Y; Dunklebarger M; Tiberti N; Laremore T; Simó-Servat O; Garcia-Ramirez M; Barber AJ; Gardner TW; Simó R
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2264-2274. PubMed ID: 29847632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy is a neurodegenerative disorder.
    Lynch SK; Abràmoff MD
    Vision Res; 2017 Oct; 139():101-107. PubMed ID: 28408138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6.
    Zorrilla-Zubilete MA; Yeste A; Quintana FJ; Toiber D; Mostoslavsky R; Silberman DM
    J Neurochem; 2018 Jan; 144(2):128-138. PubMed ID: 29049850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy: pathogenic mechanisms and current treatments.
    Chistiakov DA
    Diabetes Metab Syndr; 2011; 5(3):165-72. PubMed ID: 22813573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional and novel risk factors of diabetic retinopathy and research challenges.
    Tan GS; Ikram MK; Wong TY
    Curr Med Chem; 2013; 20(26):3189-99. PubMed ID: 23745545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.
    Chakravarthy H; Devanathan V
    J Mol Neurosci; 2018 Nov; 66(3):445-461. PubMed ID: 30293228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.
    Ola MS; Alhomida AS; Ferrario CM; Ahmad S
    Curr Med Chem; 2017; 24(28):3104-3114. PubMed ID: 28403787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Inflammation in Diabetic Retinopathy.
    Rübsam A; Parikh S; Fort PE
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy and systemic vascular complications.
    Cheung N; Wong TY
    Prog Retin Eye Res; 2008 Mar; 27(2):161-76. PubMed ID: 18249026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and natural history of diabetic retinopathy: an overview.
    Morello CM
    Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S3-7. PubMed ID: 17720892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic retinopathy: pathogenesis and therapeutic implications].
    Pelikánová T
    Vnitr Lek; 2016; 62(7-8):620-8. PubMed ID: 27627088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.
    Masser DR; Otalora L; Clark NW; Kinter MT; Elliott MH; Freeman WM
    J Neurochem; 2017 Dec; 143(5):595-608. PubMed ID: 28902411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
    Solà-Adell C; Bogdanov P; Hernández C; Sampedro J; Valeri M; Garcia-Ramirez M; Pasquali C; Simó R
    Curr Eye Res; 2017 Sep; 42(9):1273-1286. PubMed ID: 28574750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy.
    Barcelona PF; Sitaras N; Galan A; Esquiva G; Jmaeff S; Jian Y; Sarunic MV; Cuenca N; Sapieha P; Saragovi HU
    J Neurosci; 2016 Aug; 36(34):8826-41. PubMed ID: 27559166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss.
    Barber AJ
    Sci China Life Sci; 2015 Jun; 58(6):541-9. PubMed ID: 25951929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic retinopathy--biomolecules and multiple pathophysiology.
    Ahsan H
    Diabetes Metab Syndr; 2015; 9(1):51-4. PubMed ID: 25450817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systems.
    Phipps JA; Jobling AI; Greferath U; Fletcher EL; Vessey KA
    Clin Exp Optom; 2012 May; 95(3):282-9. PubMed ID: 22594546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.